These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22000927)

  • 41. L-arginine promotes gut hormone release and reduces food intake in rodents.
    Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
    Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appetite, food intake and gut hormone responses to intense aerobic exercise of different duration.
    Holliday A; Blannin A
    J Endocrinol; 2017 Dec; 235(3):193-205. PubMed ID: 28870887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.
    Belinova L; Kahleova H; Malinska H; Topolcan O; Windrichova J; Oliyarnyk O; Kazdova L; Hill M; Pelikanova T
    PLoS One; 2017; 12(4):e0174820. PubMed ID: 28369078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
    Bergmann NC; Lund A; Gasbjerg LS; Meessen ECE; Andersen MM; Bergmann S; Hartmann B; Holst JJ; Jessen L; Christensen MB; Vilsbøll T; Knop FK
    Diabetologia; 2019 Apr; 62(4):665-675. PubMed ID: 30683945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of phenylketonuria type meal on appetite, thermic effect of feeding and postprandial fat oxidation.
    Alfheeaid H; Gerasimidis K; Năstase AM; Elhauge M; Cochrane B; Malkova D
    Clin Nutr; 2018 Jun; 37(3):851-857. PubMed ID: 28318688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
    van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M
    Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute Effect of Resistant Starch on Food Intake, Appetite and Satiety in Overweight/Obese Males.
    Al-Mana NM; Robertson MD
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30558330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women.
    Doucet E; Laviolette M; Imbeault P; Strychar I; Rabasa-Lhoret R; Prud'homme D
    Metabolism; 2008 Oct; 57(10):1458-64. PubMed ID: 18803953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
    Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study.
    Behary P; Tharakan G; Alexiadou K; Johnson N; Wewer Albrechtsen NJ; Kenkre J; Cuenco J; Hope D; Anyiam O; Choudhury S; Alessimii H; Poddar A; Minnion J; Doyle C; Frost G; Le Roux C; Purkayastha S; Moorthy K; Dhillo W; Holst JJ; Ahmed AR; Prevost AT; Bloom SR; Tan TM
    Diabetes Care; 2019 Aug; 42(8):1446-1453. PubMed ID: 31177183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of peptide YY in appetite regulation and obesity.
    Karra E; Chandarana K; Batterham RL
    J Physiol; 2009 Jan; 587(1):19-25. PubMed ID: 19064614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
    Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
    J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of PYY[3-36] in rodent models of diabetes and obesity.
    Pittner RA; Moore CX; Bhavsar SP; Gedulin BR; Smith PA; Jodka CM; Parkes DG; Paterniti JR; Srivastava VP; Young AA
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):963-71. PubMed ID: 15197409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in the Postprandial Release of Appetite-Related Hormones Between Active and Inactive Men.
    Bøhler L; Coutinho SR; Rehfeld JF; Morgan L; Martins C
    Int J Sport Nutr Exerc Metab; 2018 Nov; 28(6):602-610. PubMed ID: 29431535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subjective satiety and plasma PYY concentration after wholemeal pasta.
    Costabile G; Griffo E; Cipriano P; Vetrani C; Vitale M; Mamone G; Rivellese AA; Riccardi G; Giacco R
    Appetite; 2018 Jun; 125():172-181. PubMed ID: 29427691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single day of mixed-macronutrient overfeeding does not elicit compensatory appetite or energy intake responses but exaggerates postprandial lipaemia during the next day in healthy young men.
    Deighton K; King AJ; Matu J; Shannon OM; Whiteman O; Long A; Huby MD; Sekula M; Holliday A
    Br J Nutr; 2019 Apr; 121(8):945-954. PubMed ID: 30696504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of restraint and disinhibition on PYY plasma levels and subjective feelings of appetite.
    Martins C; Robertson MD; Morgan LM
    Appetite; 2010 Oct; 55(2):208-13. PubMed ID: 20541573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.
    Sloth B; Davidsen L; Holst JJ; Flint A; Astrup A
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E604-9. PubMed ID: 17566112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of peptide YY in 5-fluorouracil-induced reduction of dietary intake.
    Sakai H; Kai Y; Takase K; Sato K; Kimura M; Tabata S; Yaegashi M; Sato F; Yomoto T; Narita M
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):753-9. PubMed ID: 27130783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lean and obese dietary phenotypes: differences in energy and substrate metabolism and appetite.
    Clamp L; Hehir AP; Lambert EV; Beglinger C; Goedecke JH
    Br J Nutr; 2015 Nov; 114(10):1724-33. PubMed ID: 26382929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.